Ambu and Medical Advisory Fuel Medical Group Announce Partnership

Friday, September 18, 2020

Ambu Inc., a rapidly growing pioneer of sterile, single-use medical devices, and Fuel Medical Group, the leading business advisory resource for ENTs, audiologists, otologists and universities, have entered into a partnership the companies announced today.

Under the agreement, Ambu will offer Fuel Medical entrée to a broad hospital market for services, including marketing, finance, digital strategies, professional development, and recruiting as well as advising practices on maximizing revenue and streamlining administrative operations.

In turn, Fuel Medical, which is based in Camas, Washington, will broaden Ambu’s reach into medical practices by offering an array of state-of-the-art, single-use endoscopes that include rhinolaryngoscopes, bronchoscopes, duodenoscopes and advanced monitors that increase safety and efficiency.

“This is a perfect match that will enable both companies to expand their reach into new and growing markets,” said Juan Jose Gonzalez, CEO of Ambu A/S. “Fuel Medical has such a strong reputation as a leader in business advisory that it was difficult to overlook their success. We are thrilled with the partnership and see an incredibly productive future.”

“We couldn’t be more excited about this partnership as we both believe in each other’s missions,” added Brendan Ford, Fuel Medical Group’s Co-Founder. “We have a lot of overlap in our goals, specifically when it comes to innovative ideas and building lasting relationships with our customers.”

Shawn Parker, Fuel Medical Group’s Co-Founder, said “Single-use scopes are ideal for ENT practices as they provide tremendous value due to their sanitary nature. If we can offer safer products to our members, we can help them provide exceptional care to their patients.”

Specifics about the deal were not disclosed.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here